Workflow
联盛化学(301212) - 2023 Q3 - 季度财报
RealsunChemRealsunChem(SZ:301212)2023-10-27 16:00

Financial Performance - The company's revenue for Q3 2023 was ¥115,726,078.71, a decrease of 54.16% compared to the same period last year[4]. - Net profit attributable to shareholders was ¥8,482,417.07, down 85.55% year-on-year[4]. - The net profit after deducting non-recurring gains and losses was ¥5,276,213.69, a decline of 91.28% compared to the previous year[4]. - Basic earnings per share for Q3 2023 were ¥0.08, down 85.19% year-on-year[4]. - Operating revenue for the first nine months of 2023 was CNY 516.16 million, a decrease of 33.38% compared to CNY 774.80 million in the same period of 2022, primarily due to insufficient downstream demand and intensified market competition[8]. - Net profit for the first nine months of 2023 was CNY 68.56 million, down 53.36% from CNY 146.99 million in the same period last year, mainly due to reduced sales volume and prices of key products[8]. - The net profit for Q3 2023 was CNY 68,556,581.24, a decrease of 53.3% compared to CNY 146,990,054.28 in Q3 2022[18]. - Operating profit for Q3 2023 was CNY 80,426,705.82, down from CNY 172,644,513.27 in the same period last year, reflecting a decline of 53.5%[18]. - The total profit for Q3 2023 was CNY 80,578,743.69, down from CNY 171,319,787.39 in Q3 2022, representing a decline of 52.9%[18]. Cash Flow and Assets - The operating cash flow for the year-to-date period reached ¥160,876,172.24, an increase of 914.11%[4]. - Cash flow from operating activities increased significantly by 914.11% to CNY 160.88 million, primarily due to a decrease in procurement scale and reduced payment for goods[8]. - Cash flow from operating activities generated a net amount of CNY 160,876,172.24, significantly up from CNY 15,863,771.42 in Q3 2022[19]. - The company reported a net cash outflow from investing activities of CNY -86,731,880.10, an improvement from CNY -508,777,342.35 in Q3 2022[20]. - Cash and cash equivalents at the end of Q3 2023 totaled CNY 289,948,271.82, down from CNY 323,087,376.57 at the end of Q3 2022[20]. - The company’s cash and cash equivalents decreased by 78.51% to CNY 39.29 million, primarily due to the previous year's public offering of shares and the purchase of large-denomination time deposits[9]. Assets and Liabilities - Total assets at the end of Q3 2023 were ¥1,667,071,220.18, reflecting a 1.10% increase from the end of the previous year[4]. - The company's equity attributable to shareholders was ¥1,340,856,491.66, up 2.10% from the end of the previous year[4]. - Non-current assets rose to CNY 626,532,039.02, up from CNY 487,434,501.11, indicating a growth of 28.6%[15]. - The total liabilities decreased to CNY 292,825,960.56 from CNY 303,585,791.80, a reduction of 3.8%[16]. - The company's total assets increased to CNY 1,667,071,220.18 from CNY 1,648,907,339.15, showing a growth of 1.1%[16]. - The retained earnings increased to CNY 438,658,701.09 from CNY 412,439,275.31, reflecting a growth of 6.4%[16]. Operational Metrics - The company reported a significant decrease in accounts receivable, down 61.49% to ¥50,424,062.78, primarily due to a decline in revenue[7]. - The company experienced a 31.97% decrease in trading financial assets, attributed to reduced bank wealth management investments[7]. - Operating costs decreased by 30.12% to CNY 410.20 million from CNY 587.01 million, attributed to the decline in operating revenue[8]. - Total operating costs amounted to CNY 444,801,201.61, down 26.1% from CNY 602,229,041.28 year-over-year[17]. - Inventory decreased to CNY 92,198,777.63 from CNY 107,264,309.16, reflecting a decline of 14.1%[14]. - The company incurred asset impairment losses of CNY -74,043.06 in Q3 2023, compared to CNY -965,634.24 in Q3 2022[18]. Non-Recurring Items - Non-recurring gains for Q3 2023 totaled ¥3,206,203.38, with government subsidies contributing ¥3,822,774.69[5]. - The company reported a financial expense reduction of 53.27%, amounting to CNY -20.37 million, due to smaller exchange rate fluctuations[8]. - Investment income showed a loss of CNY 624,679.32, a decline of 137.27% compared to a profit of CNY 1.68 million in the previous year, mainly due to foreign exchange contract settlement losses[8]. - The company received CNY 22,436,139.35 in tax refunds during Q3 2023, compared to CNY 47,129,883.28 in the previous year, a decrease of 52.5%[19]. - The company’s deferred income rose by 62.44% to CNY 21.00 million, attributed to an increase in government subsidies received during the period[8]. - The company reported a significant increase in deferred income from CNY 12,928,556.72 to CNY 21,001,066.18, an increase of 62.3%[16]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,236, with the largest shareholder, Liansheng Chemical Group, holding 52.78% of the shares[11].